Effect of carryover of clot activators on coagulation tests during phlebotomy.
Fukugawa Y, Ohnishi H, Ishii T, Tanouchi A, Sano J, Miyawaki H, Kishino T, Ohtsuka K, Yoshino H, Watanabe T
Purpose
The purpose of this paper was to determine the effects of clot activators on coagulation testing.
Conclusion
The addition of clot activators in vitro to specimens intended for coagulation testing resulted in minimal but significant changes in prothrombin time (PT) and activated partial thromboplastin time (aPTT). On the other hand, fibrin monomer complex (FMC) was significantly and remarkably affected by the addition of clot activator fluid containing thrombin. In specimens from healthy individuals and patients on warfarin, PT was minimally but significantly affected by tube draw order when coagulation tubes were drawn before and after serum tubes containing clot activator. Fibrinogen was also affected by tube draw order, but only for specimens from patients on warfarin. Other coagulation parameters were not affected by tube draw order.
Studies (2)
Purpose
The purpose of this study was to determine the effects of the addition of clot activator fluid to blood specimens in vitro on PT, aPTT, fibrinogen, D-dimer, and FMC measurements. Specimens were collected in sodium citrate Venoject II tubes, and clot activator fluid was added which had been prepared by adding saline to Venoject II tubes containing either thrombin and glass particles or only glass particles, or by adding saline to Vacutainer tubes containing silica particles. Coagulation testing was performed immediately after centrifugation.
Summary of Findings
PT was significantly increased by the addition of any amount of clot activator fluid containing thrombin, glass particles, or silica particles, but all values were within 3% of the controls (saline added). aPTT was significantly decreased and FMC was significantly increased by the addition of thrombin clot activator fluid, and the changes were proportional to the amount of fluid added. The effects of glass and silica particle clot activator fluid on aPTT and FMC were minimal. Fibrinogen and D-dimer were generally not affected by the addition of any clot activator fluid, although some random significant changes were observed.
Biospecimens
FluidBloodPreservation Types
None (Fresh)Diagnoses
NormalPlatforms
MorphologyHematology/ auto analyzerGlycoproteinHematology/ auto analyzerPeptideHematology/ auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Biospecimen components 10 uL clot activator fluid10 uL saline2 uL clot activator fluid2 uL saline5 uL clot activator fluid5 uL salineGlass particlesSilica particlesThrombin and glass particles
Purpose
The purpose of this study was to determine the effects of draw order when using a serum tube containing thrombin and glass particles and a coagulation tube containing sodium citrate on PT, aPTT, fibrinogen, D-dimer, and FMC measurements. Blood specimens were collected in the following order: plain tube with no additives, coagulation tube with sodium citrate, serum tube with thrombin and glass particles, and another coagulation tube. The butterfly needle inside the serum tube was purposefully soaked in the blood specimen during draw to maximize the possibility of clot activator contamination in the last coagulation tube.
Summary of Findings
Among specimens from healthy volunteers and patients on warfarin, the average PT ratio and international normalized ration (INR) were lower in the coagulation tube drawn after the serum tube containing clot activator than in the coagulation tube drawn before the serum tube. For specimens from patients on warfarin, fibrinogen was significantly higher in the coagulation tube drawn after the serum tube compared to the one drawn before. No other differences in coagulation tests were noted between the two coagulation tubes for healthy volunteers or patients on warfarin.
Biospecimens
FluidBloodPreservation Types
None (Fresh)Diagnoses
NormalCardiovascular DiseasePlatforms
MorphologyHematology/ auto analyzerGlycoproteinHematology/ auto analyzerPeptideHematology/ auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Other drugs NoneWarfarinBiospecimen Acquisition Type of collection container/solution Coagulation tube with sodium citratePlain tubeSerum tube with thrombin and glass particlesBiospecimen Aliquots and Components Aliquot sequential collection Plasma tube filled after plain tubePlasma tube filled after serum tube containing clot activator